Neervannan Seshadri — SEC Form 4 filings
SEC reporting owner CIK 1827584. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-11 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 6 filings — 39,705 shares, $2,513,759 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 8,366 shares @ $76.67 ($641,421) in Tarsus Pharmaceuticals, Inc., filed 2026-03-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Chief Operating Officer | 12 | — | 10 legs · 39,705 sh · $2,513,759 | 20 |
Form 4 filings — Neervannan Seshadri
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 4,564 @ $85 | EDGAR |
| 2026-03-24 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 2,989 @ $66.75 | EDGAR |
| 2026-03-19 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 3,125 @ $69.42 · Sale (S): 3,610 @ $68.71 · Sale (S): 4,589 @ $67 | EDGAR |
| 2026-03-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 26,287 · Option exercise (M): 5,097 (derivative) @ $0 · Option exercise (M): 8,148 (derivative) @ $0 · Option exercise (M): 8,020 (derivative) @ $0 · Option exercise (M): 5,022 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 27,310 (derivative) @ $0 · Grant/award (A): 17,161 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 8,366 @ $76.67 | EDGAR |
| 2025-12-18 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Gift (G): 950 @ $0 · Gift (G): 475 @ $0 | EDGAR |
| 2025-03-20 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 2,605 @ $46.29 · Sale (S): 2,543 @ $47.40 · Sale (S): 2,435 @ $50.11 | EDGAR |
| 2025-03-18 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 21,264 · Option exercise (M): 5,097 (derivative) @ $0 · Option exercise (M): 8,148 (derivative) @ $0 · Option exercise (M): 8,019 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 30,628 (derivative) @ $0 · Grant/award (A): 20,089 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 13,245 · Sale (S): 4,879 @ $30.60 · Option exercise (M): 5,097 (derivative) @ $0 · Option exercise (M): 8,148 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 47,500 (derivative) @ $0 · Grant/award (A): 32,079 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1827584 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →